Cancer Immunology |
Autore | Subramanian Subree |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (316 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
NKG2D
CAR T IL-7 prostate cancer cell therapy CD19-CAR-T B cell aplasia KIR PD-1 inhibitory CAR tumor-infiltrating lymphocytes tumor microenvironment immunotherapy NK cells cancer stem cells (CSCs) antibody-dependent cellular cytotoxicity (ADCC) differentiation cytotoxicity IFN-γ osteoclasts MICA/B mAb DNA methylation RNA methylation S-adenosylmethionine (SAM) cancer innate immunity adaptive immunity T cells m6A PD-L1 resistance immune checkpoints cancer vaccine combination immunotherapy TCR diversity organ transplantation carcinoma epidemiologic studies immunosuppression CTLA-4 Treg cells immune checkpoint inhibitors CD28 antigen-presenting cells IL15 colon cancer melanoma uveal BAP1 anti-PD-1 anti-CTLA-4 TIL classical and endemic Kaposi Sarcoma systemic treatment multi-state modelling treatment free interval chemotherapy interferon triple negative breast cancer immunomodulation bispecific antibody sortase A chemo-enzymatic approach anti-CD20 antibody Fab BiFab colorectal cancer dendritic cells Atypical Chemokine Receptor 4 (ACKR4) T-cell priming immune checkpoint blockade primary liver cancer kynurenine pathway immune evasion indoleamine 2,3 dioxygenase 1 tryptophan 2,3 dioxygenase 2 IDO inhibitor antigen presenting cells |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557349203321 |
Subramanian Subree
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Enhancing Mesenchymal Stem Cells (MSCs) for Therapeutic Purposes |
Autore | Ylostalo Joni H |
Pubbl/distr/stampa | Basel, : MDPI Books, 2022 |
Descrizione fisica | 1 electronic resource (204 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
cell therapy
immunomodulation polyunsaturated fatty acid CD206 phagocytosis mesenchymal stem cells Vadadustat AKB-6548 preconditioning priming secretome chemotaxis Wharton’s jelly mesenchymal stem cells umbilical cord oxygen conditions secretory profile neuroprotection mesenchymal stromal cells 3D culture neurospheres spheroids pluripotency neural quiescence mesothelioma malignant pleural mesothelioma (MPM) liver cirrhosis placenta-derived mesenchymal stem cells WKYMVm combination therapy iPSC-derived MSCs iMSC secretome pre-conditioning angiogenesis IFN-γ hypoxia potentiation of iMSC efficacy nanofiber-hydrogel composite spinal cord injury inflammation macrophages secondary injury astrocytes axon growth adipose tissue-derived stem cells (ASCs) autophagy rapamycin 3-methyladenine immunosuppression exosome engineered cardiac patches adipose-derived stem cell paracrine potential osteogenic differentiation hepatocyte growth factor fibroblast growth factor 2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Enhancing Mesenchymal Stem Cells |
Record Nr. | UNINA-9910595079403321 |
Ylostalo Joni H
![]() |
||
Basel, : MDPI Books, 2022 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Systemic Autoinflammatory Diseases-Clinical Rheumatic Challenges |
Autore | Feist Eugen |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (266 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
gout
febuxostat colchicine hepatotoxicity prophylaxis myositis inflammatory idiopathic myopathy dysphagia aspiration pneumonia immunoglobulin G4-related orbital disease (IgG4-ROD) orbital lymphoma (OL) computed tomography (CT) Hounsfield unit imaging autoinflammation arthritis CAPS FCAS MWS CINCA NOMID hearing loss urticarial-like rash autoinflammatory disease anti-IL-1 treatment rheumatoid arthritis synovitis neoplasms edema inflammation new genetic variant monogenic autoinflammatory syndrome diagnostic delay anakinra damage index genetic inheritance personalized therapy Interleukin-1 autoinflammatory diseases FMF coronavirus SARS-CoV-2 antibody response adult-onset Still's disease autoinflammatory disorder systemic-onset juvenile idiopathic arthritis haemophagocytic lymphohistiocytosis macrophage activation syndrome IFN-γ JAK inhibitor proliferation DNA damage repair γH2AX PBMCs T lymphocytes proteasome autoimmune proteasome-associated autoinflammatory syndrome therapy IL-1 inhibitors NGS SURF spondyloarthritis human leukocyte antigen undifferentiated enthesitis and/or arthritis ASAS classification criteria clinical management canakinumab cytokines |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557349503321 |
Feist Eugen
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|